JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo
| Autor: | Gallipoli, Paolo, Cook, Amy, Rhodes, Susan, Hopcroft, Lisa, Wheadon, Helen, Whetton, Anthony D., Jørgensen, Heather G., Bhatia, Ravi, Holyoake, Tessa L. * |
|---|---|
| Zdroj: | In Blood 28 August 2014 124(9):1492-1501 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|